Analyst Reco. Biomea Fusion, Inc.

Equities

BMEA

US09077A1060

Market Closed - Nasdaq Other stock markets 02:00:01 07/05/2024 am IST			5-day change	1st Jan Change
12.26 ^USD	-0.73%		+14.05%	-15.56%

02/05	Biomea Fusion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/04	North American Morning Briefing : Powell Awaited -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biomea Fusion Shares Decline Following JPMorgan Downgrade	03/04	MT
JPMorgan Downgrades Biomea Fusion to Neutral From Overweight, Adjusts Price Target to $14 From $51	02/04	MT
Truist Securities Starts Biomea Fusion With Buy Rating, $55 Price Target	06/02	MT
Scotiabank Starts Biomea Fusion at Sector Outperform With $41 Price Target	27/23/27	MT
Barclays Adjusts Biomea Fusion Price Target to $60 From $50, Maintains Overweight Rating	26/23/26	MT
Piper Sandler Adjusts Biomea Fusion Price Target to $45 From $40, Maintains Overweight Rating	26/23/26	MT
Jefferies Downgrades Biomea Fusion to Hold From Buy, Cuts Price Target to $28 From $36	26/23/26	MT
Piper Sandler Adjusts Price Target on Biomea Fusion to $45 From $40, Maintains Overweight Rating	26/23/26	MT
JPMorgan Chase Adjusts Price Target on Biomea Fusion to $51 From $38, Maintains Overweight Rating	26/23/26	MT
Citigroup Raises Biomea Fusion's Price Target to $90 From $53, Keeps Buy Rating	26/23/26	MT
HC Wainwright Adjusts Biomea Fusion Price Target to $50 From $37, Maintains Buy Rating	26/23/26	MT
JPMorgan Raises Biomea Fusion's Price Target to $38 From $37, Maintains Overweight Rating	20/23/20	MT
EF Hutton Assumes Biomea Fusion at Buy With $32 Price Target	25/23/25	MT
Citigroup Adjusts Price Target on Biomea Fusion to $53 From $55, Keeps Buy Rating	18/23/18	MT
Barclays Initiates Biomea Fusion at Overweight With $50 Price Target	12/23/12	MT
HC Wainwright Adjusts Price Target on Biomea Fusion to $37 From $44, Maintains Buy Rating	19/23/19	MT
HC Wainwright Adjusts Price Target on Biomea Fusion to $37 From $44, Keeps Buy Rating	19/23/19	MT
Oppenheimer Adjusts Biomea Fusion Price Target to $47 From $25, Maintains Outperform Rating	29/23/29	MT
Citigroup Adjusts Biomea Fusion's Price Target to $60 From $20, Maintains Buy Rating	29/23/29	MT
EF Hutton Adjusts Price Target on Biomea Fusion to $33 From $22, Maintains Buy Rating	28/23/28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Biomea Fusion, Inc.

Equities

BMEA

US09077A1060

Analyst Reco.

Filters